We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$48.6B
AUM Growth
-$4.2B
(-8%)
Cap. Flow
+$3.6B
Cap. Flow
% of AUM
7.4%
Top 10 Holdings %
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
964
Reduced
740
Closed
743
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$340M |
| 2 |
Bank of America
BAC
|
+$302M |
| 3 |
Cigna
CI
|
+$294M |
| 4 |
TSMC
TSM
|
+$275M |
| 5 |
Union Pacific
UNP
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$426M |
| 2 |
S&P Global
SPGI
|
+$413M |
| 3 |
Booking.com
BKNG
|
+$264M |
| 4 |
Comcast
CMCSA
|
+$256M |
| 5 |
Teleflex
TFX
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.96% |
| 3 | Technology | 16.37% |
| 4 | Consumer Discretionary | 9.33% |
| 5 | Industrials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
O-I Glass
OI
$1.39B
| $281K | ﹤0.01% |
+20,077
| New | +$289K |
|
3027
PDS Biotechnology
PDSB
$38.1M
| $281K | ﹤0.01% |
76,745
-93,734
| -55% | -$446K |
|
3028
Invesco S&P 500 Pure Growth ETF
RPG
$2.04B
| $281K | ﹤0.01% |
+9,500
| New | +$307K |
|
|
CURO
3029
DELISTED
CURO Group Holdings Corp.
CURO
| $281K | ﹤0.01% |
+50,676
| New | +$464K |
|
3030
Kadant
KAI
$3.69B
| $280K | ﹤0.01% |
1,532
+345
| +29% | +$64.3K |
|
3031
Schwab US Dividend Equity ETF
SCHD
$102B
| $280K | ﹤0.01% |
11,700
-253,566
| -96% | -$6.45M |
|
3032
Arq
ARQ
$86.7M
| $280K | ﹤0.01% |
59,670
-54,150
| -48% | -$295K |
|
|
PYCR
3033
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $279K | ﹤0.01% |
+10,746
| New | +$274K |
|
3034
Arch Capital
ACGL
$36.1B
| $278K | ﹤0.01% |
6,113
-30,691
| -83% | -$1.42M |
|
3035
MGP Ingredients
MGPI
$378M
| $278K | ﹤0.01% |
+2,775
| New | +$261K |
|
|
GHL
3036
DELISTED
Greenhill & Co., Inc.
GHL
| $278K | ﹤0.01% |
30,283
-11,669
| -28% | -$143K |
|
3037
Claros Mortgage Trust
CMTG
$306M
| $277K | ﹤0.01% |
+16,512
| New | +$312K |
|
3038
iShares Global Healthcare ETF
IXJ
$4.11B
| $276K | ﹤0.01% |
+3,400
| New | +$284K |
|
3039
Simmons First National
SFNC
$3.35B
| $276K | ﹤0.01% |
+13,000
| New | +$316K |
|
|
GRTS
3040
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $276K | ﹤0.01% |
114,034
-200,349
| -64% | -$526K |
|
3041
Gladstone Capital
GLAD
$425M
| $275K | ﹤0.01% |
+13,651
| New | +$309K |
|
3042
iShares MSCI Emerging Markets ETF
EEM
$28B
| $273K | ﹤0.01% |
+6,800
| New | +$285K |
|
3043
Mohawk Industries
MHK
$6.9B
| $273K | ﹤0.01% |
2,200
-534
| -20% | -$70.9K |
|
3044
Sun Communities
SUI
$15B
| $273K | ﹤0.01% |
1,712
-4,540
| -73% | -$762K |
|
|
VSTO
3045
DELISTED
Vista Outdoor Inc.
VSTO
| $271K | ﹤0.01% |
+9,735
| New | +$347K |
|
3046
Liberty Broadband Class C
LBRDK
$4.15B
| $269K | ﹤0.01% |
2,300
-5,313
| -70% | -$647K |
|
|
CHUY
3047
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $267K | ﹤0.01% |
13,425
-180,487
| -93% | -$4.14M |
|
3048
Teekay
TK
$975M
| $265K | ﹤0.01% |
+91,895
| New | +$301K |
|
3049
Cannae Holdings
CNNE
$647M
| $263K | ﹤0.01% |
13,603
-66,166
| -83% | -$1.39M |
|
3050
Forestar Group
FOR
$1.44B
| $263K | ﹤0.01% |
+19,144
| New | +$301K |
|
Similar funds
Marshall Wace's Q2 2022 Portfolio in Review
As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 964 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.
- Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
- Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
- Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
- Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
- Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
- Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
- Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.
Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.